Aniline and Its Analogs

The author is a Ph.D. holder from National Chemical Laboratory (NCL), Pune, India, which is one of the most prestigious institutes in the world. He has about 35 years of experience in Synthetic Organic Chemistry, Medicinal Chemistry, Biochemistry, Molecular Biology, Biotechnology, especially five years on Human Genome Project at Baylor College of Medicine, Houston, Texas. He has worked in small, medium and multinational companies in India and USA in senior positions as Associate Director, General Manager, Vice President, President and CEO and also as an Entrepreneur. He was responsible for leading large groups (up to 70-80 people) and developing drug molecules both as New Chemical Entities (NCEs) and cost-effective process development of commercially required drugs as antihistamines, anticancer, anti-diabetes, drugs for heart diseases, obesity, and also specialty chemicals. The processes involved multi-step synthesis of the drugs under these headings and also intermediates for drug molecules. He has

published about 18 publications in international journals and has 13 patents to his credit. He is an invited speaker at conferences, colleges, institutes and industries and a Chief Guest and a Key-Note Speaker at a UGC Conference. He has published a book on Cancer, "Understanding Cancer at the Subcellular Level," published by Nova Publishers, New York, USA.